Edge Rewrite
// HTMLRewriter · presentation

This page was redesigned at the edge.

Cloudflare fetched the original article and streamed it through HTMLRewriter to apply an entirely new visual system without rebuilding the source page.

// request.cf · coarse context

A page that knows where it met you.

Only coarse request metadata is shown. This demo does not display or persist visitor IP addresses.

Country
US
Cloudflare location
CMH
Connection
HTTP/2
Language
Not provided

Ray ID: a24e6fecc878b23b

Jump to content

// Workers AI · dad joke modeWhat did counterirritant say? "I'm against you.

From Wikipedia, the free encyclopedia
(Redirected from Counterirritation)

A counterirritant is a substance which creates irritation or mild inflammation in one location with the goal of lessening discomfort and/or inflammation in another location.[1] This strategy falls into the more general category of counterstimulation.

Topical counter-irritants are non-analgesic, non-anesthetic substances or treatments used to treat pain. Capsaicin, menthol (mint oil), methyl salicylate, and camphor are examples of counterirritants. Heat and cold therapy and massage relieve pain by counterstimulation.[citation needed]

The US Food and Drug Administration defines a counterirritant as "An externally applied substance that causes irritation or mild inflammation of the skin for the purpose of relieving pain in muscles, joints and viscera distal to the site of application. They differ from the anesthetics, analgesics, and antipruritic agents, however, in that the pain relief they produce results from stimulation—rather than depression—of the cutaneous sensory receptors and occurs in structures of the body other than the skin areas to which they are applied as for example, in joints, muscles, tendons and certain viscera. The use of these products dates from antiquity."[2]

References

[edit]
  1. "Definition of Counterirritant". Merriam Webster. Archived from the original on 14 March 2022. Retrieved 14 March 2022.
  2. Federal Register | Vol. 44, No. 234. California (CA): Food and Drug Administration (FDA). 4 December 1979. Archived from the original on 14 March 2022.